PF-477736

DB12611InvestigationalSmall molecule

PF-00477736 has been used in trials studying the treatment of Neoplasms.

Mechanism: Pharmacologically active on Serine/threonine-protein kinase Chk1
Curator reviewed
Formula / weight: C₂₂H₂₅N₇O₂ · 419.489 g/mol (avg)
Code names: PF-00477736

Resolves to

Compound

Structure

InChIKeyNDEXUOWTGYUVGA-LJQANCHMSA-NSMILESCN1C=C(C=N1)C1=C2C=NNC(=O)C3=C2C(N1)=CC(NC(=O)[C@H](N)C1CCCCC1)=C3

Targets

What you can answer from here — as of August 26, 2024

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with PF-477736, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.